Increased maternal serum alpha‐fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome
- 1 August 1992
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 12 (8), 643-647
- https://doi.org/10.1002/pd.1970120804
Abstract
Intrauterine fetal death occurred in four women who were ‘screen-positive’ in a screening programme for neural tube defects (NTDs) and Down syndrome (DS). These women had very high levels of maternal serum alpha-fetoprotein (MSAFP) and maternal serum human chorionic gonadotropin (MShCG). Therefore, we evaluated all ‘screen-positive’ women in whom both of these markers were ⩾ 2.0 multiples of the median. The cases fulfilling these criteria totalled 11, and only one of them had no complications. High concentrations of both MSAFP and MShCG in a number of these cases might have been caused by an increased placental volume, which, in turn, might have been induced by decreased perfusion of the placenta. We conclude that screening programmes wrongly determine a high risk of fetal NTD or DS if the concentrations of both these parameters are very high. Invasive diagnostic procedures should be avoided in these cases, particularly in view of the increased risk of an adverse pregnancy outcome.Keywords
This publication has 12 references indexed in Scilit:
- Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum α-fetoprotein elevation presage adverse perinatal outcome?American Journal of Obstetrics and Gynecology, 1991
- New developments in pre-eclampsiaFetal and Maternal Medicine Review, 1990
- Evaluation of Evaluations in Maternal Serum Alfa FetoprotienObstetrical & Gynecological Survey, 1990
- Placental histology and the production of human choriogonadotrophin and its subunits in pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- Outcomes in patients with unusually high maternal serum α-fetoprotein levelsAmerican Journal of Obstetrics and Gynecology, 1987
- Raised maternal serum alpha‐fetoprotein in the absence of fetal abnormality‐placental findings. A quantitative morphometric studyPrenatal Diagnosis, 1986
- RAISED MATERNAL SERUM-ALPHA-FETOPROTEIN LEVELS AND SPONTANEOUS FETOMATERNAL TRANSFUSIONThe Lancet, 1979
- SIGNIFICANCE OF ELEVATED MID-TRIMESTER MATERNAL PLASMA-ALPHA-FETOPROTEIN VALUESThe Lancet, 1979